DIAQUIP LIMITED

Company Registration Number:
09352205 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2022

Period of accounts

Start date: 01 January 2022

End date: 31 December 2022

DIAQUIP LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2022

Company Information - 3
Balance sheet - 4
Additional notes - 6
Balance sheet notes - 9

DIAQUIP LIMITED

Company Information

for the Period Ended 31 December 2022




Director: G Barry Jones
Registered office: Clippers House
Clippers Quay
Salford Quays
Salford
Greater Manchester
GBR
M50 3XP
Company Registration Number: 09352205 (England and Wales)

DIAQUIP LIMITED

Balance sheet

As at 31 December 2022


Notes

2022
£

2021
£
Fixed assets
Total fixed assets: - -
Current assets
Debtors: 19,808 14,133
Cash at bank and in hand: 3,498,712 5,892,287
Total current assets: 3,518,520 5,906,420
Creditors: amounts falling due within one year: ( 3,401,897 ) ( 5,822,607 )
Net current assets (liabilities): 116,623 83,813
Total assets less current liabilities: 116,623 83,813
Total net assets (liabilities): 116,623 83,813

The notes form part of these financial statements

DIAQUIP LIMITED

Balance sheet continued

As at 31 December 2022


Notes

2022
£

2021
£
Capital and reserves
Called up share capital: 100 100
Revaluation reserve: 4 95,733 68,597
Profit and loss account: 20,790 15,116
Shareholders funds: 116,623 83,813

For the year ending 31 December 2022 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 26 October 2023
And Signed On Behalf Of The Board By:

Name: G Barry Jones
Status: Director

The notes form part of these financial statements

DIAQUIP LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

DIAQUIP LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

  • 2. Employees


    2022

    2021
    Average number of employees during the period 0 0

    The company has no employees in the UK, it contracts out to independent service providers. In the countries of its markets, where English is not the first language, it networks with sub-dealers and other contractors including clinical and medical specialists.

DIAQUIP LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

  • 3. Off balance sheet disclosure

    No

DIAQUIP LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

4. Revaluation reserve


2022
£
Balance at 01 January 2022 68,597
Surplus or deficit after revaluation 27,136
Balance at 31 December 2022 95,733

Although the company reports in GBP, trading solely involves EUR and USD and therefore the difference from the exchange rates solely used for reporting in GBP are held in reserve.